Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Group
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1340	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1340	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1340	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1442	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1631	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1672	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1792	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.1852	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2014	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2305	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2358	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2512	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2595	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2597	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.2636	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3038	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3062	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3152	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3200	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3431	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3501	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3553	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3595	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3778	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.3933	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.4229	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.4317	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.4496	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.4602	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.4735	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.4810	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5028	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5465	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5656	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5661	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5714	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5774	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.5822	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.6405	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.6631	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.6667	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.6917	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.6989	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.7070	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.7750	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.7766	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.7807	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	0.8273	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.8308	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	0.9839	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.0000	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	1.0497	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.0836	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.1189	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.2298	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.2616	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.2759	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.3098	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.3521	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.4149	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.5116	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.6226	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.6433	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	1.7520	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	1.7900	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	2.1606	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	2.2713	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	2.4078	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	2.5075	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	3.3546	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	3.4856	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	3.8239	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	3.8855	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	4.0131	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	4.0274	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	4.0437	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	4.1449	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	4.7312	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.0312	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.0952	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.1863	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.2213	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.5041	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.6686	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	5.7827	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	6.0289	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	6.0558	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	6.1433	Peak area	Lean
Reversed phase POSITIVE ION MODE	dihydroorotate	6.5955	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	6.6106	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	7.3940	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	7.5544	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	8.5216	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	8.9484	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	8.9702	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	9.2710	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	9.7565	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	12.2481	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	dihydroorotate	14.0277	Peak area	Obese non neuropathy